Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
35.27
-13.71
-38.87%
Share Warrants & Outstandings
Total Reserve
-167.80
28.52
-196.32
-688.36%
Shareholder's Funds
-146.24
63.79
-210.03
-329.25%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
161.25
39.40
121.85
309.26%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
161.25
39.40
121.85
309.26%
Deferred Tax Assets / Liabilities
0.00
-5.15
5.15
100.00%
Other Long Term Liabilities
45.00
0.16
44.84
28,025.00%
Long Term Trade Payables
2.44
0.00
2.44
0.00%
Long Term Provisions
3.06
0.11
2.95
2,681.82%
Total Non-Current Liabilities
211.75
34.52
177.23
513.41%
Current Liabilities
Trade Payables
18.15
11.38
6.77
59.49%
Other Current Liabilities
33.63
3.85
29.78
773.51%
Short Term Borrowings
50.96
0.00
50.96
0.00%
Short Term Provisions
0.79
0.00
0.79
0.00%
Total Current Liabilities
103.53
15.23
88.30
579.78%
Total Liabilities
169.04
113.54
55.50
48.88%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.11
24.02
290.09
1,207.70%
Less: Accumulated Depreciation
168.40
0.12
168.28
140,233.33%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.70
23.90
121.80
509.62%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.24
3.51
-2.27
-64.67%
Intangible assets under development
1.85
0.00
1.85
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
52.61
-52.61
-100.00%
Long Term Loans & Advances
9.98
12.66
-2.68
-21.17%
Other Non Current Assets
0.00
7.90
-7.90
-100.00%
Total Non-Current Assets
158.78
100.86
57.92
57.43%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.03
9.77
-3.74
-38.28%
Sundry Debtors
0.05
0.16
-0.11
-68.75%
Cash and Bank
0.14
0.47
-0.33
-70.21%
Other Current Assets
0.47
0.07
0.40
571.43%
Short Term Loans and Advances
3.56
2.21
1.35
61.09%
Total Current Assets
10.26
12.68
-2.42
-19.09%
Net Current Assets (Including Current Investments)
-93.27
-2.55
-90.72
-3,557.65%
Total Current Assets Excluding Current Investments
10.26
12.68
-2.42
-19.09%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
169.04
113.54
55.50
48.88%
Contingent Liabilities
8.47
0.00
8.47
0.00%
Total Debt
212.21
39.40
172.81
438.60%
Book Value per share (adjusted)
-67.83
18.09
-85.92
-474.96%
Annual - Borrowings
Borrowings 212.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 146.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
